News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,890 Results
Type
Article (48975)
Company Profile (260)
Press Release (685655)
Section
Business (215302)
Career Advice (2519)
Deals (36467)
Drug Delivery (110)
Drug Development (83826)
Employer Resources (175)
FDA (16782)
Job Trends (15622)
News (362212)
Policy (34508)
Tag
Academia (2729)
Alliances (52961)
Alzheimer's disease (1355)
Approvals (16761)
Artificial intelligence (229)
Bankruptcy (363)
Best Places to Work (12035)
Biotechnology (184)
Breast cancer (239)
Cancer (1834)
Cardiovascular disease (139)
Career advice (2110)
CAR-T (133)
Cell therapy (395)
Clinical research (67406)
Collaboration (722)
Compensation (387)
COVID-19 (2714)
C-suite (176)
Data (1712)
Diabetes (227)
Diagnostics (6513)
Earnings (89463)
Employer resources (152)
Events (117582)
Executive appointments (606)
FDA (17750)
Funding (643)
Gene therapy (275)
GLP-1 (710)
Government (4669)
Healthcare (19651)
Infectious disease (2835)
Inflammatory bowel disease (132)
Interviews (433)
IPO (16732)
Job creations (4041)
Job search strategy (1778)
Layoffs (467)
Legal (8580)
Lung cancer (265)
Manufacturing (256)
Medical device (13688)
Medtech (13693)
Mergers & acquisitions (20129)
Metabolic disorders (604)
Neuroscience (1797)
NextGen: Class of 2025 (6919)
Non-profit (4800)
Northern California (2211)
Obesity (331)
Opinion (236)
Patents (178)
People (59799)
Phase I (20909)
Phase II (29548)
Phase III (22199)
Pipeline (801)
Postmarket research (2824)
Preclinical (8997)
Radiopharmaceuticals (252)
Rare diseases (350)
Real estate (6284)
Regulatory (23102)
Research institute (2439)
Resumes & cover letters (412)
Southern California (1902)
Startups (3761)
United States (19599)
Vaccines (670)
Weight loss (239)
Date
Today (137)
Last 7 days (822)
Last 30 days (2836)
Last 365 days (35314)
2025 (5587)
2024 (36143)
2023 (40975)
2022 (52259)
2021 (56969)
2020 (55647)
2019 (48619)
2018 (36732)
2017 (33802)
2016 (33721)
2015 (39693)
2014 (33858)
2013 (29338)
2012 (31253)
2011 (31654)
2010 (30086)
Location
Africa (880)
Arizona (216)
Asia (40918)
Australia (6793)
California (5053)
Canada (1762)
China (427)
Colorado (233)
Connecticut (251)
Europe (90179)
Florida (740)
Georgia (175)
Illinois (490)
Indiana (278)
Maryland (780)
Massachusetts (3862)
Michigan (210)
Minnesota (345)
New Jersey (1444)
New York (1441)
North Carolina (914)
Northern California (2211)
Ohio (180)
Pennsylvania (1140)
South America (1264)
Southern California (1902)
Texas (732)
Utah (154)
Washington State (478)
734,890 Results for "john wiley and sons inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wiley Announces Quarterly Dividend
December 12, 2024
·
1 min read
Partnered
From Theory to Practice: Johns Hopkins Design Team Sets Undergrads Up for Success
At Johns Hopkins University, the biomedical engineering program’s Design Team offering lets undergraduates dive deep into clinical projects that can help them land industry jobs, get provisional patents or even start companies.
November 6, 2024
·
6 min read
·
BioSpace Insights
Drug Development
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the safety of SON-1010 dosing has been formally reviewed in both of the current Phase 1 clinical trials and the Company is now increasing the target dose of SON-1010 during dose escalation.
May 20, 2024
·
11 min read
Business
Wiley Hosts Investor Update
Wiley (NYSE: WLY and WLYB), one of the world’s largest publishers and a global leader in research and learning, will host its Investor Update today at 10 am E.T. to discuss the company’s business and financial outlook.
January 25, 2024
·
5 min read
Press Releases
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas
January 21, 2025
·
10 min read
Business
Wiley Schedules Second Quarter 2024 Earnings Release and Conference Call
Wiley will release its second quarter 2024 results prior to market open on Wednesday, December 6, 2023.
November 29, 2023
·
1 min read
Press Releases
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
October 9, 2024
·
8 min read
Press Releases
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
January 23, 2025
·
8 min read
Press Releases
Wiley to Reveal Key Insights and AI-Driven Innovations at Frankfurt Book Fair
October 16, 2024
·
4 min read
Business
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27.
June 25, 2024
·
2 min read
1 of 73,489
Next
